This article systematically summarizes the neuroprotective effects and mechanisms of ginsenosides Rg1, Rb1, and rare ginsenosides against Parkinson's disease (PD) and Alzheimer's disease (AD). The key findings indicate that ginsenosides exert their beneficial effects by modulating various signaling pathways related to inflammation, oxidative stress, apoptosis, and autophagy.